170 related articles for article (PubMed ID: 10978392)
21. The course of anticardiolipin antibody levels under immunoadsorption therapy.
Hauser AC; Hauser L; Pabinger-Fasching I; Quehenberger P; Derfler K; Hörl WH
Am J Kidney Dis; 2005 Sep; 46(3):446-54. PubMed ID: 16129206
[TBL] [Abstract][Full Text] [Related]
22. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus.
Burt RK; Traynor A; Statkute L; Barr WG; Rosa R; Schroeder J; Verda L; Krosnjar N; Quigley K; Yaung K; Villa Bs M; Takahashi M; Jovanovic B; Oyama Y
JAMA; 2006 Feb; 295(5):527-35. PubMed ID: 16449618
[TBL] [Abstract][Full Text] [Related]
23. [Induction of remission in severe lupus erythematosus by intensified therapy].
Euler HH; Schroeder JO; Harten P; Mass B; Gutschmidt HJ; Löffler H
Immun Infekt; 1989 Apr; 17(2):51-3. PubMed ID: 2714833
[TBL] [Abstract][Full Text] [Related]
24. Successful pregnancy and delivery in a case of systemic lupus erythematosus treated with immunoadsorption therapy and cyclosporin A.
Maeshima E; Yamada Y; Kodama N; Mune M; Yukawa S
Scand J Rheumatol; 1999; 28(1):54-7. PubMed ID: 10092166
[TBL] [Abstract][Full Text] [Related]
25. B cell loss leading to remission in severe systemic lupus erythematosus.
Tarrant TK; Frazer DH; Aya-Ay JP; Patel DD
J Rheumatol; 2003 Feb; 30(2):412-4. PubMed ID: 12563705
[TBL] [Abstract][Full Text] [Related]
26. Extracorporeal immunoadsorption: initial experience in human systemic lupus erythematosus.
Terman DS; Buffaloe G; Mattioli C; Cook G; Tillquist R; Sullivan M; Ayus JC
Lancet; 1979 Oct; 2(8147):824-7. PubMed ID: 90920
[TBL] [Abstract][Full Text] [Related]
27. Cyclosporin A and therapeutic plasma exchange in the treatment of severe systemic lupus erythematosus.
Bambauer R; Schwarze U; Schiel R
Artif Organs; 2000 Nov; 24(11):852-6. PubMed ID: 11119071
[TBL] [Abstract][Full Text] [Related]
28. The estimation of circulating immune complexes, C3d, and anti-ds-DNA-antibody serum levels in the monitoring of therapeutic plasmapheresis in a patient with systemic lupus erythematosus. A case report.
Krapf F; Manger B; Koch B; Kraulledat P; Kalden JR
Clin Exp Rheumatol; 1985; 3(2):159-62. PubMed ID: 3874738
[TBL] [Abstract][Full Text] [Related]
29. Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus.
Schneider M; Berning T; Waldendorf M; Glaser J; Gerlach U
J Rheumatol; 1990 Jul; 17(7):900-7. PubMed ID: 2213756
[TBL] [Abstract][Full Text] [Related]
30. Effect of immunoadsorption on patient with rheumatoid arthritis or SLE.
Yamazaki Z; Fujimori Y; Iizuka I; Kanai F; Idezuki Y; Takahama T; Asano K; Takahashi K; Ogita T; Miyamoto Y
Trans Am Soc Artif Intern Organs; 1984; 30():211-6. PubMed ID: 6398545
[No Abstract] [Full Text] [Related]
31. Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption.
Amital H; Heilweil-Harel M; Ulmansky R; Harlev M; Toubi E; Hershko A; Naparstek Y
Rheumatology (Oxford); 2007 Sep; 46(9):1433-7. PubMed ID: 17686790
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.
Jasmin R; Sockalingam S; Shahrizaila N; Cheah TE; Zain AA; Goh KJ
Lupus; 2012 Sep; 21(10):1119-23. PubMed ID: 22433918
[TBL] [Abstract][Full Text] [Related]
33. Treatment of systemic lupus erythematosus by extracorporeal immunoadsorption.
Palmer A; Gjorstrup P; Severn A; Welsh K; Taube D
Lancet; 1988 Jul; 2(8605):272. PubMed ID: 2899250
[No Abstract] [Full Text] [Related]
34. Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide.
Euler HH; Schroeder JO; Harten P; Zeuner RA; Gutschmidt HJ
Arthritis Rheum; 1994 Dec; 37(12):1784-94. PubMed ID: 7986225
[TBL] [Abstract][Full Text] [Related]
35. Vasculitis secondary to staphylococcal Protein A immunoadsorption (Prosorba column) treatment in rheumatoid arthritis.
Deodhar A; Allen E; Daoud K; Wahba I
Semin Arthritis Rheum; 2002 Aug; 32(1):3-9. PubMed ID: 12219317
[TBL] [Abstract][Full Text] [Related]
36. Devic's syndrome and SLE: challenges in diagnosis and therapeutic possibilities based on two overlapping cases.
Polgár A; Rózsa C; Müller V; Matolcsi J; Poór G; Kiss EV
Autoimmun Rev; 2011 Jan; 10(3):171-4. PubMed ID: 20920613
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: an evaluation.
Turner-Stokes T; Lu TY; Ehrenstein MR; Giles I; Rahman A; Isenberg DA
Rheumatology (Oxford); 2011 Aug; 50(8):1401-8. PubMed ID: 21398661
[TBL] [Abstract][Full Text] [Related]
38. Plasmapheresis in systemic lupus erythematosus: a cautionary note.
Schlansky R; DeHoratius RJ; Pincus T; Tung KS
Arthritis Rheum; 1981 Jan; 24(1):49-53. PubMed ID: 7470171
[TBL] [Abstract][Full Text] [Related]
39. Dextran sulfate (Selesorb) plasma apheresis improves vascular changes in systemic lupus erythematosus.
Braun N; Jünger M; Klein R; Gutenberger S; Guagnin M; Risler T
Ther Apher; 2002 Dec; 6(6):471-7. PubMed ID: 12460414
[TBL] [Abstract][Full Text] [Related]
40. Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus. An interim report of the Lupus Plasmapheresis Study Group.
Euler HH; Guillevin L
Ann Med Interne (Paris); 1994; 145(5):296-302. PubMed ID: 7985935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
